The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease
Abstract
Background/aims No information is yet available about the influence of alcohol abuse on the translocation of larger molecules (Mr>1200) through the intestinal mucosa in man. The present study aimed to determine the intestinal permeability to macromolecules in patients with chronic alcohol abuse and mild to more advanced stages of liver disease, and to measure the concentration of endotoxins in the plasma, as these compounds derive from the intestinal flora and are suspected to contribute to the development of alcoholic liver disease (ALD).Methods The permeability to polyethylene glycol Mr 400, Mr 1500, Mr 4000, and Mr 10,000 and endotoxin plasma concentrations were measured in 54 patients with alcoholic liver disease, 19 of them with cirrhosis, and in 30 non-alcoholic healthy controls.Results Permeability to polyethylene glycol Mr 400 was found to be unchanged in patients with ALD in comparison to healthy controls, whereas polyethylene glycol Mr 1500 and Mr 4000 were recovered in about twice as high concentrations in the urine of ALD patients (p<0.01). Polyethylene glycol Mr 10,000 was detected significantly less frequently in urine from healthy controls (0/30) than in urine of patients with alcoholic liver disease (20/54, p<0.01). Endotoxin concentrations in the plasma of alcoholics were increased more than 5-fold compared to healthy controls (p<0.01).Conclusions The results of this study indicate that alcohol abuse impairs the function of the intestinal barrier, which might enhance the translocation of bacterial toxins, thereby contributing to inflammatory processes in alcoholic liver disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in blood LPS levels reflect gut leakiness and are mirrored by a number of other alterations such as increased intestinal permeability to high molecular weight polyethylene glycol in patients with ALD26 and to FITC-dextran in mouse models of alcoholic and biliary liver disease27,28.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [26]
Citations
Cites
Intestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927
Antibiotics prevent liver injury in rats following long-term exposure to ethanol
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692
Bode, C., Kugler, V., & Bode, J. C. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80003-x · Cited by 529
Self-citationFukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461
Self-citationLactobacillus Feeding Reduces Endotoxemia and Severity of Experimental Alcoholic Liver (Disease)
Nanji, A. A., Khettry, U., & Sadrzadeh, S. M. H. (1994) · Experimental Biology and Medicine · doi:10.3181/00379727-205-43703 · Cited by 436
THE LEAKY GUT OF ALCOHOLISM: POSSIBLE ROUTE OF ENTRY FOR TOXIC COMPOUNDS
Bjarnason, I., Ward, K., & Peters, T. B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92109-3 · Cited by 432
Goldman, R. C., & Leive, L. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04635.x · Cited by 368
Jejunal microflora in patients with chronic alcohol abuse.
Jc, B., Bode, C., Heidelbach, R., Hk, D., & Ga, M. (1984) · PubMed · Cited by 303
Self-citationIntestinal permeability in patients with Crohn's disease and their healthy relatives
Katz, K. D., Hollander, D., Vadheim, C. M., McElree, C. K., Delahunty, T., Dadufalza, V. D., Krugliak, P., & Rotter, J. I. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91499-6 · Cited by 302
Hollander, D. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011172 · Cited by 265
Research works printed but not linked: 1
- Hollander, 1988, Importance of 'probe' molecular geometry in determining intestinal permeability, Can J Gastroenterol, 2, 35A
Cited by
Sorted by citations
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Immunotherapies for hepatocellular carcinoma
Llovet, J. M., Castet, F., Heikenwalder, M., Maini, M. K., Mazzaferro, V., Pinato, D. J., Pikarsky, E., Zhu, A. X., & Finn, R. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00573-2 · Cited by 1,843
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Regulation of intestinal epithelial permeability by tight junctions
Suzuki, T. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1070-x · Cited by 1,437
The role of the gut microbiota in NAFLD
Leung, C., Rivera, L., Furness, J. B., & Angus, P. W. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.85 · Cited by 1,020
Leclercq, S., Matamoros, S., Cani, P. D., Neyrinck, A. M., Jamar, F., Stärkel, P., Windey, K., Tremaroli, V., Bäckhed, F., Verbeke, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415174111 · Cited by 972
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Alcoholic liver disease: mechanisms of injury and targeted treatment
Louvet, A., & Mathurin, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.35 · Cited by 867
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
Yan, A. W., Fouts, D. E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2011) · Hepatology · doi:10.1002/hep.24018 · Cited by 791
Villa, E., Cammà, C., Marietta, M., Luongo, M., Critelli, R. M., Colopi, S., Tata, C., Zecchini, R., Gitto, S., Petta, S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.018 · Cited by 741
Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria
Sonnenberg, G. F., Monticelli, L. A., Alenghat, T., Fung, T. C., Hutnick, N. A., Kunisawa, J., Shibata, N., Grunberg, S., Sinha, R., Zahm, A. M., et al. (2012) · Science · doi:10.1126/science.1222551 · Cited by 764
The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Bernardi, M., Moreau, R., Angeli, P., Schnabl, B., & Arroyo, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.004 · Cited by 645
Leaky Gut As a Danger Signal for Autoimmune Diseases
Mu, Q., Kirby, J. L., Reilly, C. M., & Luo, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00598 · Cited by 634
IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R. M., & Ma, T. Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4641 · Cited by 601
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Llopis, M., Cassard, A., Wrzosek, L., Boschat, L., Bruneau, A., Ferrere, G., Puchois, V., Martin, J., Lepage, P., Roy, T. L., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310585 · Cited by 578
Bull–Otterson, L., Feng, W., Kirpich, I., Wang, Y., Qin, X., Liu, Y., Gobejishvili, L., Joshi‐Barve, S., Ayvaz, T., Petrosino, J. F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053028 · Cited by 553
Gut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
Manco, M., Putignani, L., & Bottazzo, G. F. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0030 · Cited by 489
Endotoxemia and gut barrier dysfunction in alcoholic liver disease†
Rao, R. (2009) · Hepatology · doi:10.1002/hep.23009 · Cited by 476
Cirrhosis-associated immune dysfunction
Albillos, A., Martín‐Mateos, R., der Merwe, V., Wiest, R., Jalan, R., & Álvarez‐Mon, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00520-7 · Cited by 485
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Awad, W., Hess, C., & Hess, M. (2017) · Toxins · doi:10.3390/toxins9020060 · Cited by 397
Toll-Like Receptor Signaling in the Liver
Schwabe, R. F., Seki, E., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.038 · Cited by 411
Forsyth, C. B., Farhadi, A., Jakate, S. M., Tang, Y., Shaikh, M. W., & Keshavarzian, A. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.12.009 · Cited by 404
Alcohol and Gut-Derived Inflammation
Bishehsari, F. (2017) · Alcohol research · doi:10.35946/arcr.v38.2.02 · Cited by 380
Effect of alcohol consumption on the gut.
Bode, C., & Christian Bode, J. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00034-9 · Cited by 379
Self-citationThe role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Soares, J., Pimentel‐Nunes, P., Roncon‐Albuquerque, R., & Leite-Moreira, A. F. (2010) · Hepatology International · doi:10.1007/s12072-010-9219-x · Cited by 378
Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 375
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 421
Fukui, H. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000447252 · Cited by 358
Oxidative Stress, Metabolism of Ethanol and Alcohol-Related Diseases
Zima, T., Fialová, L., Mestek, O., Kalousová, M., Crkovska, J., Malbohan, I. M., Štípek, S., Mikulikova, L., & Popov, P. (2001) · Journal of Biomedical Science · doi:10.1007/bf02255972 · Cited by 354
Rao, R. K., Seth, A., & Sheth, P. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00006.2004 · Cited by 340
Toll-like receptors as targets in chronic liver diseases
Mencin, A. M., Kluwe, J., & Schwabe, R. F. (2009) · Gut · doi:10.1136/gut.2008.156307 · Cited by 340
Purohit, V., Bode, J. C., Bode, C., Brenner, D. A., Choudhry, M. A., Hamilton, F., Kang, Y. J., Keshavarzian, A., Rao, R., Sartor, R. B., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.03.131 · Cited by 325
Self-citationChen, P., Torralba, M., Tan, J., Embree, M., Zengler, K., Stärkel, P., van Pijkeren, J.-P., DePew, J., Loomba, R., Ho, S. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.09.014 · Cited by 322
Lorenzo-Zúñiga, V., Bartolí, R., Planas, R., Hofmann, A. F., Viñado, B., Hagey, L. R., Hernández, J. M., Mañé, J., Alvarez, M. A., Ausina, V., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50116 · Cited by 321
Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability
de Punder, K., & Pruimboom, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00223 · Cited by 321
Leclercq, S., Cani, P. D., Neyrinck, A. M., Stärkel, P., Jamar, F., Mikolajczak, M., Delzenne, N. M., & de Timary, P. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.04.001 · Cited by 310
The intestinal microbiota and chronic disorders of the gut
Dupont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 310
Suzuki, T., & Hara, H. (2009) · Journal of Nutrition · doi:10.3945/jn.108.100867 · Cited by 303
Exacerbation of Alcoholic Liver Injury by Enteral Endotoxin in Rats
Mathurin, P., Deng, Q.-G., Keshavarzian, A., Choudhary, S., HOLMES, E. W., & Tsukamoto, H. (2000) · Hepatology · doi:10.1053/jhep.2000.19621 · Cited by 297
Hersoug, L., Møller, P., & Loft, S. H. (2015) · Obesity Reviews · doi:10.1111/obr.12370 · Cited by 301
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 314
Hartmann, P., Hochrath, K., Horvath, A., Chen, P., Seebauer, C. T., Llorente, C., Wang, L., Alnouti, Y., Fouts, D. E., Stärkel, P., et al. (2018) · Hepatology · doi:10.1002/hep.29676 · Cited by 290
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 285
Shao, T., Zhao, C., Li, F., Gu, Z., Liu, L., Zhang, L., Wang, Y., He, L., Liu, Y., Liu, Q., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.021 · Cited by 258
Alcoholic disease: Liver and beyond
Rocco, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14652 · Cited by 260
Wang, Y., Kirpich, I., Liu, Y., Ma, Z., Barve, S. S., McClain, C. J., & Feng, W. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.039 · Cited by 255
Dose Adjustment in Patients with Liver Disease
Delc, F., Tchambaz, L., Schlienger, R. G., Drewe, J., & hl, S. K. H. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00005 · Cited by 255
Microbiome as a therapeutic target in alcohol-related liver disease
Sarin, S. K., Pande, A., & Schnabl, B. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.019 · Cited by 254
Mohammad, M. K., Zhou, Z., Cave, M. C., Barve, A. J., & McClain, C. J. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533611433534 · Cited by 248
Ferrier, L., Bérard, F., Debrauwer, L., Chabo, C., Langella, P., Bueno, L. P., & Fioramonti, J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050617 · Cited by 247
Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
Hartmann, P., Chen, P., Wang, H. J., Wang, L., McCole, D. F., Brandl, K., Stärkel, P., Belzer, C., Hellerbrand, C., Tsukamoto, H., et al. (2013) · Hepatology · doi:10.1002/hep.26321 · Cited by 246
Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., Lu, X., & Jia, M. (2012) · Toxicology · doi:10.1016/j.tox.2012.10.025 · Cited by 251
Differential liver sensitization to Toll-like receptor pathways in mice with alcoholic fatty liver
Gustot, T., Lemmers, A., Moreno, C., Nagy, N., Quertinmont, E., Nicaise, C., Franchimont, D. P., Louis, H., Deviere, J. M., & Moine, O. L. (2006) · Hepatology · doi:10.1002/hep.21138 · Cited by 249
Elamin, E. E., Masclee, A., Jan, D., Pieters, H., & Jonkers, D. M. A. E. (2013) · Journal of Nutrition · doi:10.3945/jn.113.179549 · Cited by 237
D-livering the message: The importance of vitamin D status in chronic liver disease
Kitson, M. T., & Roberts, S. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.033 · Cited by 242
Wang, Y., Liu, Y., Sidhu, A., Ma, Z., McClain, C. J., & Feng, W. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2012 · Cited by 238
The Role of Acetaldehyde in the Actions of Alcohol (Update 2000)
Eriksson, C. J. P. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02369.x · Cited by 235
Role of flavonoids in intestinal tight junction regulation
Suzuki, T., & Hara, H. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.08.001 · Cited by 233
Mihm, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103104 · Cited by 232
Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
Arab, J. P., Martín‐Mateos, R., & Shah, V. H. (2017) · Hepatology International · doi:10.1007/s12072-017-9798-x · Cited by 233
Nagy, L. E. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800803 · Cited by 227
Neuroimmune signaling in alcohol use disorder
Erickson, E. K., Grantham, E. K., Warden, A. S., & Harris, R. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.007 · Cited by 238
Pathogenesis of Alcoholic Liver Disease
Dunn, W., & Shah, V. H. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.02.004 · Cited by 221
The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation
Vanuytsel, T., Tack, J. F., & Farré, R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.717925 · Cited by 242
González‐Quintela, A., Alonso‐Sampedro, M., Franco, J. C., Vizcaíno, L., Loidi, L., & Gudé, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054600 · Cited by 221
Leclercq, S., De Saeger, C., Delzenne, N., de Timary, P., & Stärkel, P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.02.003 · Cited by 216
The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction
Zhong, W., McClain, C. J., Cave, M., Kang, Y. J., & Zhou, Z. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00350.2009 · Cited by 214
Intestinal Barrier and Permeability in Health, Obesity and NAFLD
Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q. ‐., & Ciaula, A. D. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 219
Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia
Bauer, T. M., Schwacha, H., Steinbruckner, B., Brinkmann, F. E., Ditzen, A. K., Aponte, J. J., Pelz, K., Berger, D., Kist, M., & Blum, H. E. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05791.x · Cited by 211
Gut‐liver axis at the frontier of host‐microbial interactions
Brandl, K., Kumar, V., & Eckmann, L. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00361.2016 · Cited by 201
A Critical Involvement of Oxidative Stress in Acute Alcohol-Induced Hepatic TNF-α Production
Zhou, Z., Wang, L., Song, Z., Lambert, J. C., McClain, C. J., & Kang, Y. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63473-6 · Cited by 203
The Role of Acetaldehyde in the Actions of Alcohol (Update 2000)
Eriksson, C. J. P. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200105051-00005 · Cited by 205
Effects of dietary components on intestinal permeability in health and disease
Khoshbin, K., & Camilleri, M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2020 · Cited by 206
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
Fukui, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.425 · Cited by 201
Liver architecture, cell function, and disease
Ishibashi, H., Nakamura, M., Komori, A., Migita, K., & Shimoda, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0155-6 · Cited by 208
Ethanol metabolism and its effects on the intestinal epithelial barrier
Elamin, E. E., Masclee, A., Dekker, J. P., & Jonkers, D. M. A. E. (2013) · Nutrition Reviews · doi:10.1111/nure.12027 · Cited by 188
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
Day, C., & SAKSENA, S. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.31.x · Cited by 187
Wang, Y., TONG, J., Chang, B., Wang, B., Zhang, D., & Wang, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2126 · Cited by 177
Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease
Yan, C., Hu, W., Tu, J., Li, J., Liang, Q., & Han, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04166-8 · Cited by 195
The link between inflammation, bugs, the intestine and the brain in alcohol dependence
Leclercq, S., de Timary, P., Delzenne, N. M., & Stärkel, P. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.15 · Cited by 174
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
Parker, R., Kim, S.-J., & Gao, B. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.116 · Cited by 175
Kupffer Cell Metabolism and Function.
Nguyen‐Lefebvre, A. T., & Horuzsko, A. (2015) · PubMed · Cited by 174
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Schwenger, K. J. P., Clermont‐Dejean, N. M., & Allard, J. P. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.04.004 · Cited by 179
Alisi, A., Carpino, G., de Oliveira, F. L., Panera, N., Nobili, V., & Gaudio, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/8162421 · Cited by 172
Pathogenesis of alcohol‐induced liver disease: Classical concepts and recent advances
Seth, D., Haber, P. S., Syn, W., Diehl, A. M., & Day, C. P. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06756.x · Cited by 166
Assimakopoulos, S. F., Tsamandas, A. C., Tsiaoussis, G. I., Karatza, E., Triantos, C. K., Vagianos, C., Spiliopoulou, I. T., Kaltezioti, V., CHARONIS, A. S., Nikolopoulou, V. N., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02609.x · Cited by 166
Toll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Role of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 155
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Fukui, H. (2019) · Diseases · doi:10.3390/diseases7040058 · Cited by 159
SYSTEMIC INFLAMMATION INCREASES INTESTINAL PERMEABILITY DURING EXPERIMENTAL HUMAN ENDOTOXEMIA
Hietbrink, F., Besselink, M. G., Renooij, W., de Smet, M. D., Draisma, A., van der Hoeven, H., & Pickkers, P. (2009) · Shock · doi:10.1097/shk.0b013e3181a2bcd6 · Cited by 142
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives
Malaguarnera, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16639 · Cited by 149
Nagy, L. E. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132258 · Cited by 145
Brun, P., Castagliuolo, I., Pinzani, M., Palù, G., & Martines, D. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00537.2004 · Cited by 147
The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Seo, Y. S., & Shah, V. H. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.4.337 · Cited by 141
Metadata
- Authors
- Parlesak, A., Schäfer, C., Schütz, T., Bode, J. C., & Bode, C.
- Affiliations
- University of Hohenheim (DE)
- Robert Bosch Hospital (DE)
- ORCID
- Parlesak, Alexandr
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 32
- Issue
- 5
- Pages
- 742-747
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2017851289
- Cited by
- 647
- References
- 40
- Citations by year
- 2026: 14 · 2025: 25 · 2024: 35 · 2023: 30 · 2022: 37 · 2021: 49 · 2020: 37 · 2019: 34 · 2018: 35 · 2017: 45 · 2016: 32 · 2015: 52 · 2014: 29 · 2013: 26 · 2012: 29
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, macromolecules, endotoxemia, chronic alcohol abuse, alcoholic liver disease, alcoholic cirrhosis, intestinal barrier dysfunction, polyethylene glycol, bacterial translocation, endotoxin, gut microbiota
- MeSH terms
- Adult, Aged, Alcoholism, Cell Membrane Permeability, Endotoxins, Female, Humans, Intestinal Mucosa, Intestines, Liver Cirrhosis, Alcoholic, Male, Middle Aged, Polyethylene Glycols, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review